-
2025-520632-42-00
axial or predominantly axial SpA with or without psoria 5
-
2025-521259-21-00
PSORIATIC ARTHRITIS 6
-
2024-514388-24-00
Knee osteoarthritis 4
-
2025-523971-46-00
Diffuse cutaneous systemic sclerosis (dcSSc)
Difficult 7
-
2024-517948-66-00
Piriformis muscle syndrome 4
-
2025-522471-28-00
psoriatic arthritis (PsA) 5
-
2025-523153-33-00
LOW BACK PAIN 5
-
2026-525317-31-00
Retractile Capsulitis 4
-
2025-521301-40-00
Prevention of new morphometric vertebral fractures and/ 6
-
2026-525343-33-00
Polymyalgia rheumatica 4
-
2025-523213-29-00
X-linked myotubular myopathy 7
-
2026-525604-99-00
Knee osteoarthritis 1
-
2023-509109-57-01
Total Hip Arthroplasty / THA 6
-
2024-515312-50-00
Systemic sclerosis 6
-
2025-524057-13-00
Achilles tendinopathy 5
-
2026-525608-85-00
Paraffin Oil Induced Granulomatous Disease 10
-
2025-521331-36-00
Patient with stabilized SSc-ILD (as defined by a declin 10
-
2024-517010-15-01
Post-operative recovery after hip fracture surgery in f 3
-
2023-504427-61-01
piriformis hypertonia 6
-
2023-508604-37-00
Non-transfusion dependent beta-thalassemia (NTDT), Beta 4
-
2024-519004-27-00
Duchenne Muscular Dystrophy 7
-
2025-522546-52-00
patients with chronic respiratory insufficiency due to 5
-
2024-511656-41-00
Duchenne Muscular Dystrophy 4
-
2026-526142-27-01
Deformity 5